Weak macro signals, rising AI competition, and analyst downgrades triggered a broad sell-off across software and cloud names.

Senior leadership roles at Guardant Health, Genentech and PfizerRegulatory, clinical and commercial expertise in therapeutics and biomarkersWill assist with osteosarcoma regulatory advice and oncology ...

Guardant Health, Inc. stock outlook: strong oncology growth and liquid biopsy adoption drive revenue. Click for this updated ...

Guardant Health (GH) has drawn fresh attention as investors look at its recent share performance alongside its growing precision oncology business, including liquid biopsy tests and data services for ...

Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 5.9% in the afternoon session after the company announced ...

Guardant Health, Inc. (NASDAQ:GH) is one of the best high growth healthcare stocks to buy now. Guardant Health, Inc.

Guardant Health, Inc. (NASDAQ:GH) said real-world evidence generated through its InfinityAI platform helped support the ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that real-world evidence generated from Guardant's InfinityAI contributed to the recent approval of ENHERTU® ...

March is National Colorectal Cancer Awareness Month, and for Grey’s Anatomy and Memory of a Killer’s Patrick Dempsey, who is no stranger to playing roles defined by health, creating an environment ...

Guardant Health, Inc. (NASDAQ:GH) is one of the best growth stocks to buy according to billionaires. As of March 13, 2026, Guardant Health carried a Moderate Buy consensus from 23 analysts, based on ...

Guardant Health Inc. stock grades by Barron's. View GH fundamental and sentiment analysis powered by MarketGrader.

Guardant Health Inc. (NASDAQ:GH) is one of the best cancer stocks to invest in now. On February 23, Guardant Health Inc. (NASDAQ:GH) completed the acquisition of the health technology company ...